Charles Schwab Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Hold |
8,848
| – | – | 0.02% | 172 |
|
|
2025
Q1 | $224K | Buy |
+8,848
| New | +$224K | 0.02% | 163 |
|
|
2024
Q2 | – | Sell |
-8,582
| Closed | -$238K | – | 156 |
|
|
2024
Q1 | $238K | Sell |
8,582
-19,358
| -69% | -$537K | 0.02% | 142 |
|
|
2023
Q4 | $804K | Sell |
27,940
-15,926
| -36% | -$459K | 0.08% | 97 |
|
|
2023
Q3 | $1.46M | Buy |
43,866
+5,197
| +13% | +$172K | 0.16% | 70 |
|
|
2023
Q2 | $1.47M | Buy |
38,669
+3,691
| +11% | +$140K | 0.18% | 61 |
|
|
2023
Q1 | $1.43M | Sell |
34,978
-6,615
| -16% | -$270K | 0.17% | 64 |
|
|
2022
Q4 | $2.13M | Buy |
41,593
+9,439
| +29% | +$484K | 0.28% | 51 |
|
|
2022
Q3 | $1.41M | Sell |
32,154
-706
| -2% | -$30.9K | 0.24% | 60 |
|
|
2022
Q2 | $1.72M | Buy |
32,860
+672
| +2% | +$35.2K | 0.36% | 47 |
|
|
2022
Q1 | $1.67M | Sell |
32,188
-1,410
| -4% | -$73K | 0.29% | 54 |
|
|
2021
Q4 | $1.98M | Buy |
33,598
+35
| +0.1% | +$2.07K | 0.32% | 45 |
|
|
2021
Q3 | $1.44M | Sell |
33,563
-10,605
| -24% | -$456K | 0.28% | 67 |
|
|
2021
Q2 | $1.73M | Buy |
44,168
+5,710
| +15% | +$224K | 0.34% | 58 |
|
|
2021
Q1 | $1.4M | Buy |
38,458
+4,038
| +12% | +$147K | 0.29% | 67 |
|
|
2020
Q4 | $1.27M | Buy |
34,420
+12,265
| +55% | +$451K | 0.3% | 70 |
|
|
2020
Q3 | $771K | Sell |
22,155
-1,923
| -8% | -$66.9K | 0.24% | 77 |
|
|
2020
Q2 | $746K | Buy |
24,078
+1,561
| +7% | +$48.4K | 0.25% | 81 |
|
|
2020
Q1 | $697K | Sell |
22,517
-10,126
| -31% | -$313K | 0.29% | 76 |
|
|
2019
Q4 | $1.21M | Buy |
32,643
+18,529
| +131% | +$689K | 0.47% | 55 |
|
|
2019
Q3 | $474K | Buy |
+14,114
| New | +$474K | 0.22% | 85 |
|